Product Image
InnoPED-α vaccine
Components
- Porcine Epidemic Diarrhea virus HID9047
- Adjuvant ISA206
Efficacy and effectiveness
- Prevention of Porcine Epidemic Diarrhea
- Recent Prevalent Type (G2 strain) PEDV
- Inactivated vaccine with high neutralizing antibody formation ability
Usage and Capacity
- For sows, vaccinate twice at 5 weeks before every farrowing and 3 weeks after 1st vaccination
- Shake enough vaccine before use
InnoPED-α
- Vaccine applied innovative INNOVAC new technology to prevent Porcine Epidemic Diarrhea
Product Overview
| Product Name | InnoPED-α |
|---|---|
| Time for vaccination | For sows, vaccinate twice at 5 weeks before every farrowing and 3 weeks after 1st vaccination |
| Vaccination method | Injection twice by Intramuscular injection with 2mL of vaccine |
| Efficacy and Effectiveness | Prevention of Porcine Epidemic Diarrhea |
Product Properties
- Recent Trend Type (G2 strain) PEDV
- High potency PEDV, enough vaccine antigen content
- Inactivated vaccine with high neutralizing antibody formation ability
Symptoms of Porcine Epidemic Diarrhea (PED)
Product Distinct Value
- PED Vaccine with INNOVAC’s new technology solves problems with existing swine Epidemic Diarrhea Vaccine.
- Compared to conventional vaccines, it showed an excellent defense effect through high immunogenicity (neutralizing antibody) induction.
- InnoPED-α Vaccine confirmed outperformance in comparative test with existing PED Products.
- Neutralizing antibodies in serum are excellent after mother pig delivery.
- Neutralizing antibodies are excellent in the first milk after mother pig delivery.
- The mother-transferred neutralizing antibodies are excellent in piglets.
Product Distinct Value
